These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 2863338

  • 1. Relapse of Graves' disease after medical therapy: predictive value of thyroidal technetium-99m uptake and serum thyroid stimulating hormone receptor antibody levels.
    Wilson R, McKillop JH, Pearson DW, Cuthbert GF, Thomson JA.
    J Nucl Med; 1985 Sep; 26(9):1024-8. PubMed ID: 2863338
    [Abstract] [Full Text] [Related]

  • 2. Prediction of remission in Graves' disease treated with long-term carbimazole therapy: evaluation of technetium-99m thyroid uptake and TSH concentrations as prognostic indicators.
    Prakash R.
    Eur J Nucl Med; 1996 Feb; 23(2):118-22. PubMed ID: 8925844
    [Abstract] [Full Text] [Related]

  • 3. Continued suppression of serum TSH level may be attributed to TSH receptor antibody activity as well as the severity of thyrotoxicosis and the time to recovery of thyroid hormone in treated euthyroid Graves' patients.
    Chung YJ, Lee BW, Kim JY, Jung JH, Min YK, Lee MS, Lee MK, Kim KW, Chung JH.
    Thyroid; 2006 Dec; 16(12):1251-7. PubMed ID: 17199435
    [Abstract] [Full Text] [Related]

  • 4. Prediction of outcome in Graves' disease after carbimazole treatment.
    Weetman AP, Ratanachaiyavong S, Middleton GW, Love W, John R, Owen GM, Darke C, Lazarus JH, Hall R, McGregor AM.
    Q J Med; 1986 Apr; 59(228):409-19. PubMed ID: 2875484
    [Abstract] [Full Text] [Related]

  • 5. Prediction of remission after antithyroid drug treatment in Graves' disease.
    Young ET, Steel NR, Taylor JJ, Stephenson AM, Stratton A, Holcombe M, Kendall-Taylor P.
    Q J Med; 1988 Feb; 66(250):175-89. PubMed ID: 2902655
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The prognostic value of TSH receptor binding and thyroid stimulating antibodies following antithyroid drug treatment of Graves' disease.
    Wilson R, Fraser WD, McKillop JH, Thomson JA.
    Acta Endocrinol (Copenh); 1989 Nov; 121(5):666-70. PubMed ID: 2573989
    [Abstract] [Full Text] [Related]

  • 8. Thyroid function and immunological activity during and after medical treatment of Graves' disease.
    Gossage AA, Crawley JC, Copping S, Hinge D, Himsworth RL.
    Clin Endocrinol (Oxf); 1983 Jul; 19(1):87-96. PubMed ID: 6137296
    [Abstract] [Full Text] [Related]

  • 9. Optimum duration of antithyroid drug treatment determined by assay of thyroid stimulating antibody in patients with Graves' disease.
    Edan G, Massart C, Hody B, Poirier JY, Lé Reun M, Hespel JP, Leclech G, Simon M.
    BMJ; 1989 Feb 11; 298(6670):359-61. PubMed ID: 2564286
    [Abstract] [Full Text] [Related]

  • 10. Medical therapy of Graves' disease: does thyroxine prevent recurrence of hyperthyroidism?
    Lucas A, Salinas I, Rius F, Pizarro E, Granada ML, Foz M, Sanmartí A.
    J Clin Endocrinol Metab; 1997 Aug 11; 82(8):2410-3. PubMed ID: 9253309
    [Abstract] [Full Text] [Related]

  • 11. Prediction of the course of Graves' disease after medical antithyroid treatment.
    Eshøj O, Kvetny J, Mogensen EF, Bech K, Bliddal H.
    Acta Med Scand; 1985 Aug 11; 217(2):225-8. PubMed ID: 2859737
    [Abstract] [Full Text] [Related]

  • 12. Relapse of Graves' disease after successful outcome of antithyroid drug therapy: results of a prospective randomized study on the use of levothyroxine.
    Hoermann R, Quadbeck B, Roggenbuck U, Szabolcs I, Pfeilschifter J, Meng W, Reschke K, Hackenberg K, Dettmann J, Prehn B, Hirche H, Mann K, Basedow Study Group.
    Thyroid; 2002 Dec 11; 12(12):1119-28. PubMed ID: 12593726
    [Abstract] [Full Text] [Related]

  • 13. Epitope mapping of tsh receptor-blocking antibodies in Graves' disease that appear during pregnancy.
    Kung AW, Lau KS, Kohn LD.
    J Clin Endocrinol Metab; 2001 Aug 11; 86(8):3647-53. PubMed ID: 11502791
    [Abstract] [Full Text] [Related]

  • 14. Graves' disease: thyroid function and immunologic activity.
    Gossage AA, Crawley JC, Copping S, Hinge D, Himsworth RL.
    J Nucl Med; 1982 Nov 11; 23(11):973-7. PubMed ID: 6290623
    [Abstract] [Full Text] [Related]

  • 15. Reappraisal of the 3,5,3'-triiodothyronine-suppression test in the prediction of long term outcome of antithyroid drug therapy in patients with hyperthyroid Graves' disease.
    Yamada T, Koizumi Y, Sato A, Hashizume K, Aizawa T, Takasu N, Nagata H.
    J Clin Endocrinol Metab; 1984 Apr 11; 58(4):676-80. PubMed ID: 6421866
    [Abstract] [Full Text] [Related]

  • 16. Lack of effect of thyroxine administration on elevated thyroid stimulating hormone receptor antibody levels in treated Graves' disease patients.
    Tamai H, Hayaki I, Kawai K, Komaki G, Matsubayashi S, Kuma K, Kumagai LF, Nagataki S.
    J Clin Endocrinol Metab; 1995 May 11; 80(5):1481-4. PubMed ID: 7744989
    [Abstract] [Full Text] [Related]

  • 17. Sensitive thyrotropin and thyrotropin-receptor antibody determinations one month after discontinuation of antithyroid drug treatment as predictors of relapse in Graves' disease.
    Quadbeck B, Hoermann R, Roggenbuck U, Hahn S, Mann K, Janssen OE, Basedow Study Group.
    Thyroid; 2005 Sep 11; 15(9):1047-54. PubMed ID: 16187913
    [Abstract] [Full Text] [Related]

  • 18. Graves' ophthalmopathy in the absence of elevated free thyroxine and triiodothyronine levels: prevalence, natural history, and thyrotropin receptor antibody levels.
    Khoo DH, Eng PH, Ho SC, Tai ES, Morgenthaler NG, Seah LL, Fong KS, Chee SP, Choo CT, Aw SE.
    Thyroid; 2000 Dec 11; 10(12):1093-100. PubMed ID: 11201855
    [Abstract] [Full Text] [Related]

  • 19. Effect of thyrotropin-releasing hormone on serum thyroid hormones: a study in the patients with untreated and treated Graves' disease and subacute thyroiditis.
    Sato A, Yamada T, Aizawa T, Ichikawa K, Komiya I, Takasu N, Takemura Y.
    J Clin Endocrinol Metab; 1995 Jul 11; 80(7):2173-7. PubMed ID: 7608274
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.